Jacobs MS - Search Results

1

Screening for Atrial Fibrillation in Sub-Saharan Africa: A Health Economic Evaluation to Assess the Feasibility in Nigeria.

Jacobs MS, Adeoye AM, Owolabi MO, Tieleman RG, Postma MJ, Van Hulst M. Jacobs MS, et al. Glob Heart. 2021 Dec 3;16(1):80. doi: 10.5334/gh.893. eCollection 2021. Glob Heart. 2021. PMID: 34900571 Free PMC article.

2

Predictors for total hospital and cardiology cost claims among patients with atrial fibrillation initiating dabigatran or acenocoumarol in The Netherlands.

Jacobs MS, van Leent MWJ, Tieleman RG, Jansman FGA, Cao Q, Postma MJ, van Hulst M. Jacobs MS, et al. J Med Econ. 2017 Dec;20(12):1231-1236. doi: 10.1080/13696998.2017.1363766. Epub 2017 Aug 22. J Med Econ. 2017. PMID: 28766370 Free article.

3

The cost-effectiveness and monetary benefits of dabigatran in the prevention of arterial thromboembolism for patients with non-valvular atrial fibrillation in the Netherlands.

van Hulst M, Stevanovic J, Jacobs MS, Tieleman RG, Kappelhoff B, Postma MJ. van Hulst M, et al. Among authors: jacobs ms. J Med Econ. 2018 Jan;21(1):38-46. doi: 10.1080/13696998.2017.1372222. Epub 2017 Sep 7. J Med Econ. 2018. PMID: 28836865 Free article.

4

Health economic evaluation of rivaroxaban in elective cardioversion of atrial fibrillation.

Jacobs MS, de Jong LA, Postma MJ, Tieleman RG, van Hulst M. Jacobs MS, et al. Eur J Health Econ. 2018 Sep;19(7):957-965. doi: 10.1007/s10198-017-0942-2. Epub 2017 Nov 27. Eur J Health Econ. 2018. PMID: 29181817 Free PMC article.

5

Incidence, treatment and mortality of new-onset atrial fibrillation patients at the intensive care unit.

Jacobs MS, Loef B, Reidinga AC, Postma MJ, Van Hulst M, Tieleman RG. Jacobs MS, et al. Open Heart. 2020 Apr 6;7(1):e001226. doi: 10.1136/openhrt-2019-001226. eCollection 2020. Open Heart. 2020. PMID: 32509315 Free PMC article.

6

Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.

Jacobs MS, Kaasenbrood F, Postma MJ, van Hulst M, Tieleman RG. Jacobs MS, et al. Europace. 2018 Jan 1;20(1):12-18. doi: 10.1093/europace/euw285. Europace. 2018. PMID: 27733465

7

Perioperative bridging of vitamin K antagonist treatment in patients with atrial fibrillation: only a very small group of patients benefits.

van der Pol S, Jacobs MS, Meijer K, Piersma-Wichers MG, Tieleman RG, Postma MJ, van Hulst M. van der Pol S, et al. Among authors: jacobs ms. Europace. 2019 May 1;21(5):716-723. doi: 10.1093/europace/euy308. Europace. 2019. PMID: 30649301

8

Atrial Fibrillation in Africa-An Under-Reported and Unrecognized Risk Factor for Stroke: A Systematic Review.

Jacobs MS, van Hulst M, Adeoye AM, Tieleman RG, Postma MJ, Owolabi MO. Jacobs MS, et al. Glob Heart. 2019 Sep;14(3):269-279. doi: 10.1016/j.gheart.2019.04.003. Epub 2019 May 15. Glob Heart. 2019. PMID: 31103399 Free article.

9

Inappropriate non-vitamin K antagonist oral anticoagulants prescriptions: be cautious with dose reductions.

Jacobs MS, van Hulst M, Campmans Z, Tieleman RG. Jacobs MS, et al. Neth Heart J. 2019 Jul;27(7-8):371-377. doi: 10.1007/s12471-019-1267-9. Neth Heart J. 2019. PMID: 30949972 Free PMC article.

10

Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands.

van Hulst M, Tieleman RG, Zwart LAR, Pomp M, Jacobs MS, Meeder JG, van Ofwegen-Hanekamp CEE, Hollander M, Smits P, Hemels MEW. van Hulst M, et al. Among authors: jacobs ms. Eur Heart J Qual Care Clin Outcomes. 2023 Jun 21;9(4):408-416. doi: 10.1093/ehjqcco/qcac042. Eur Heart J Qual Care Clin Outcomes. 2023. PMID: 35881482 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters